RETRACTED ARTICLE: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma

Osteosarcoma (OS) is the most common primary malignant bone tumor. However, the therapeutic results of the advanced cases at the first visit were still extremely poor. Therefore, more effective therapeutic options based on molecular profiling of OS are needed. In this study, we investigated the func...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasa, Keita, Saito, Tsuyoshi, Kurihara, Taisei, Hasegawa, Nobuhiko, Sano, Kei, Kubota, Daisuke, Akaike, Keisuke, Okubo, Taketo, Hayashi, Takuo, Takagi, Tatsuya, Yao, Takashi, Ishijima, Muneaki, Suehara, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777567/
https://www.ncbi.nlm.nih.gov/pubmed/35201455
http://dx.doi.org/10.1007/s12672-021-00453-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777567/
https://www.ncbi.nlm.nih.gov/pubmed/35201455
http://dx.doi.org/10.1007/s12672-021-00453-2

Ejemplares similares